Antipodean Advisors’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Antipodean Advisors’s Portfolio CMAX Stock Details CMAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$424K	Sell	6,667 -7,500	-53%	-$525K	2.17%	7
2023 Q2	$1.32M	Hold	14,167	–	–	9.37%	5
2023 Q1	$1.13M	Hold	14,167	–	–	7.02%	5
2022 Q4	$1.55M	Hold	14,167	–	–	5.18%	4
2022 Q3	$3.01M	Hold	14,167	–	–	7.71%	5
2022 Q2	$1.54M	Hold	14,167	–	–	2.51%	8
2022 Q1	$3.17M	Sell	14,167 -5,833	-29%	-$1.21M	2.3%	5
2021 Q4	$4.61M	Hold	20,000	–	–	1.89%	6
2021 Q3	$5.8M	Hold	20,000	–	–	1.64%	8
2021 Q2	$7.72M	Buy	+20,000	New	+$7.94M	2.13%	6

Other funds holding CMAX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Antipodean Advisors's CMAX Position: Q3 2023 in Review

Antipodean Advisors reduced its CareMax, Inc. Class A Common Stock (CMAX) stake by 53% in Q3 2023, selling an estimated $525K and leaving 6,667 shares worth $424K. The position accounts for 2.17% of the portfolio, ranked #7.

Antipodean Advisors first reported a position in CMAX in Q2 2021 and has held it in 10 quarters since. The position peaked at $7.72M in Q2 2021. 71 funds tracked by Wall St. Rank hold CMAX as of Q3 2023.

Antipodean Advisors held 6,667 shares of CareMax, Inc. Class A Common Stock worth $424K as of Q3 2023.
Antipodean Advisors sold 7,500 CareMax, Inc. Class A Common Stock shares in Q3 2023, an estimated $525K.
CareMax, Inc. Class A Common Stock made up 2.17% of Antipodean Advisors's portfolio in Q3 2023, its #7 holding.
Antipodean Advisors first reported a position in CareMax, Inc. Class A Common Stock in Q2 2021 and has held it in 10 quarters since.
Antipodean Advisors's CareMax, Inc. Class A Common Stock position peaked at $7.72M in Q2 2021.
71 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q3 2023.

Based on Antipodean Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.